Hello Adithya,
I think there are good opportunities in the Pharma segment. Please go through the respective threads on Valuepickr to know more about each company. I am more bullish on the CDMO space and the NCE (New Chemical Entity) led opportunities. Not qualified to recommend so pls do your due diligence.
My take way is this new Specialty steel division, currently only 1 company in India is making these products , Krishca will be the second one.
My take way is this new Specialty steel division, currently only 1 company in India is making these products , Krishca will be the second one.
Thanks for the response.
Is it possible to add these metrics to the sheet now…if you can guide a procedure to add this so that data gets pulled from the site.
Thanks for the response.
Is it possible to add these metrics to the sheet now…if you can guide a procedure to add this so that data gets pulled from the site.
Nice entry position as per technicals.
Also, at 5year low P/B
Current regulatory environment is understandable, but quality stock available at lucrative price.
Disc: Invested, no transactions in last 30 days
Nice entry position as per technicals.
Also, at 5year low P/B
Current regulatory environment is understandable, but quality stock available at lucrative price.
Disc: Invested, no transactions in last 30 days
PAT negative growth q1 fy25 yoy instead of positive sale growth why ? Please give your suggestion
PAT negative growth q1 fy25 yoy instead of positive sale growth why ? Please give your suggestion
Then why promoter chooses such a route of asirvad ipo?@maheshkumar, @ sudhakar